CASI Pharmaceuticals OverviewCASI Pharmaceuticals Net Income
Profitability analysis for CASI.
Quarterly Net Income
-$10.88M
↓ 29.64% YoY
As of Sep 2025
Annual Net Income (TTM)
-$49.38M
↓ 62.7% YoY
Trailing 12 months ending Sep 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...